Skip to main content
BrainCited

Vitamin E 관련 Age-Related Cognitive Decline

C

High-dose vitamin E may slow functional decline in moderate Alzheimer's disease (TEAM-AD trial). Results are mixed for cognitive decline prevention in healthy populations.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dvitamin\u002De\u0026condition\u003Dcognitive\u002Ddecline'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

결론

High-dose vitamin E may slow functional decline in moderate Alzheimer's disease (TEAM-AD trial). Results are mixed for cognitive decline prevention in healthy populations.

Key Study Findings

Systematic Review n=80488
Vitamin E and cognitive function: A systematic review of clinical evidence.
Dose: None vs: None Outcome: cognitive function / cognitive impairment 효과: None None

대상 집단: participants from 43 clinical studies (2012-2022)

Review
Exploring the Efficacy and Safety of Nutritional Supplements in Alzheimer's Disease.
Dose: Curcumin 800mg/d, omega-3 2g/d, resveratrol 600mg/d vs: None Outcome: Cognitive decline in AD 효과: None None

대상 집단: Alzheimer's disease patients

Observational Study n=2713 Open-label
Non-linear association between dietary fiber intake and cognitive function mediated by vitamin E: a cross-sectional …
Dose: Inflection at 29.65 g/day (DSST), 22.65 g/day (composite) vs: Cross-sectional fiber intake groups Outcome: Cognitive function composite z-scores (DSST, AFT, CERAD) 효과: β=0.18 per unit fiber below inflection <0.0001

대상 집단: NHANES adults aged ≥60 years (2011-2014)

Review
The Role of Vitamins in Neurodegeneration: A Brief Review of Mechanisms, Clinical Evidence, and Therapeutic …
Dose: None vs: None Outcome: None 효과: None None

대상 집단: Review of vitamins in neurodegeneration

Review
Bioactive compounds and dietary patterns in Alzheimer's disease.
Dose: None vs: None Outcome: AD progression and cognitive decline 효과: None None

대상 집단: Elderly with or at risk of Alzheimer's disease (review)

Meta-Analysis
Associations between Diet and Cognitive Function in Stroke Survivors: A Systematic Review and Meta-analysis.
Dose: None vs: Standard care or placebo Outcome: Global cognition in stroke survivors 효과: SMD=0.62 (energy-protein); SMD=-0.40 (B-vitamins) 0.009 (protein); 0.02 (B-vit)

대상 집단: Adult stroke survivors (20 trials + 14 observational)

Key Statistics

12

연구

3000

참여자

Mixed

C

등급

Referenced Papers

Journal of Alzheimer's … 2025 3 인용
American journal of … 2025
European geriatric medicine 2023 10 인용
Nutrients 2022 76 인용
Plant foods for … 2013 155 인용
Orphanet journal of … 2011 158 인용
American family physician 2011
TheScientificWorldJournal 2009 38 인용
Clinica chimica acta; … 2006 134 인용
Archives of neurology 2002 354 인용
The Proceedings of … 2002 191 인용
Asia Pacific journal … 2002 24 인용
Current opinion in … 1998 30 인용

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

일반적으로 사용되는 용량

general:
15 mg/day (RDA)
cognitivesupport:
400-800 IU/day

상한량: 1,000 mg/day (1,500 IU natural / 1,100 IU synthetic)

연구에서 사용된 용량

용량 기간 효과 N
None -- Positive 80488
Curcumin 800mg/d, omega-3 2g/d, resveratrol 600mg/d -- Mixed --
Inflection at 29.65 g/day (DSST), 22.65 g/day (composite) -- Positive 2713
None -- Mixed --
None -- Positive --
None -- Mixed --
None -- Positive --
None -- Mixed --

권장 복용 시간: With meals containing fat

Safety & Side Effects

보고된 부작용

  • Increased bleeding risk at high doses
  • Nausea and diarrhea
  • Fatigue and weakness
  • Blurred vision

알려진 상호작용

  • Anticoagulants (increased bleeding risk)
  • Statins and niacin (may reduce HDL-raising effects)
  • Chemotherapy and radiation (may reduce efficacy)

일일 최대 섭취 허용량: 1,000 mg/day (1,500 IU natural / 1,100 IU synthetic)

건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.

Frequently Asked Questions

Does Vitamin E help with Age-Related Cognitive Decline?
Based on 12 studies with 3,000 participants, there is limited but promising evidence that Vitamin E may support Age-Related Cognitive Decline management. Our evidence grade is C (Some Evidence).
How much Vitamin E should I take for Age-Related Cognitive Decline?
Studies have used various dosages. A commonly studied range is 15 mg/day (RDA). Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Vitamin E?
Reported side effects may include Increased bleeding risk at high doses, Nausea and diarrhea, Fatigue and weakness, Blurred vision. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Vitamin E and Age-Related Cognitive Decline?
We rate the evidence as Grade C (Some Evidence). This rating is based on 12 peer-reviewed studies with 3,000 total participants. The overall direction of effect is mixed.

Related Evidence

FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.